Gliclazide is a sulfonylurea oral antidiabetic drug that stimulates pancreatic beta cells to release insulin. It is known for its moderate risk of hypoglycemia and is often used in patients with type 2 diabetes not controlled on Metformin alone. It also has antioxidant and vascular protective effects.